Medical quality and safety are essential safeguards for the harmonious society in China, directly affecting people's sense of security and happiness. Continuously improving medical quality and ensuring medical safety are fundamental and essential to implementing the strategies of the Party Central Committee and the State Council, and promoting the construction of a healthy China. In recent years, with the rapid development of China's economy and the people's increasing emphasis on their own health and safety, China's plastic surgery industry has achieved significant progress and yielded outstanding results. However, along with the rapid growth of the industry, medical quality issues and safety accidents have occurred frequently, attracting widespread attention from all sectors of society. This article briefly outlines the history of quality management and quality control for medical quality and safety in China's plastic surgery specialty. It explores the development of quality management from its origin to medical quality management, as well as the responsibilities and contributions of the National Plastic Surgery Quality Control Center in improving industry standards and ensuring patient safety. It aims to provide support for the standardized management of the plastic surgery industry in the future, so as to promote its healthy and sustainable development.

To comprehensively improve the level of standardized screening, diagnosis and treatment of hypertension, the Clinical practice guidelines for the management of hypertension in China has been jointly initiated by Chinese Society of Cardiology, Chinese Medical Association, Hypertension Committee of Cross-Straits Medicine Exchange Association, Cardiovascular Disease Prevention and Rehabilitation Committee, and Chinese Association of Rehabilitation Medicine. This guideline addresses several important clinical problems in the field of screening, diagnosis evaluation and treatment of hypertension, fully assesses the latest high-quality clinical research evidences available, and gives clear recommendations. It also advocates the new concepts and perspectives, such as moving forward the diagnosis and treatment of hypertension, promoting the target of blood pressure reduction, simplifying the risk stratification of cardiovascular diseases, and paying attention to the screening of secondary hypertension, which will help promote the prevention and treatment of hypertension in China.

Facial anthropometry has profound importance in clinical diagnosis and the recognition of abnormal facial features. With the development of anthropometry, facial anthropometry has emerged as an independent research field and is widely applied in disciplines such as plastic surgery and cranio-maxillofacial surgery. This paper reviews the evolution of facial anthropometry and discusses its future trends in the context of artificial intelligence (AI). Currently, 3D facial imaging technology can accurately capture and reconstruct the three-dimensional morphology of facial soft tissues, and enhance the precision and objectivity of measurements, thus becoming the new "gold standard" for facial anthropometry. It not only provides reference for disease diagnosis and surgical planning but also plays a crucial role in evaluating cosmetic outcomes and aging research. In recent years, AI technology has developed rapidly, enabling direct recognition of abnormal facial features. Although facial recognition systems based on two-dimensional images are relatively mature, they have to struggle to fully capture facial features as they are limited by the dimensionality of information. While three-dimensional image-based recognition boasts high accuracy, it faces challenges in the recognition and classification of abnormal facial features due to limitations in the number of training samples. The integration of AI and facial anthropometry has effectively promoted automatic recognition technology for facial landmarks, thus providing more precise and interpretable methods for assessing disease-related facial features. Future research should focus on building reliable three-dimensional facial databases to further improve the accuracy of facial recognition. Additionally, developing facial recognition systems based on small sample sizes is necessary to provide robust support for the recognition of facial features associated with rare and special diseases.

Tumor stage and lymph node involvement are the most important prognostic factors for patients with locally advanced cervical cancer. For cervical cancer, gynecologic oncologists generally apply the criteria of the International Federation of Gynecology and Obstetrics(FIGO). However, in the current FIGO 2018 staging system, stage ⅢC is based only on the anatomical location of metastatic lymph nodes, without considering local tumor factors and other lymphatic status parameters, which limits its prognostic significance to a certain extent. The aim of this article is to summarize the influence of local tumor factors and different lymphatic status parameters on prognosis and treatment options for stage ⅢC cervical cancer.

In 2005, the Acquired Immunodeficiency Syndrome Professional Group of Society of Infectious Diseases, Chinese Medical Association formulated the "Guideline for Diagnosis and Treatment of AIDS" in China (hereinafter referred to as the "Guideline"). The 2024 edition of the Guideline is revised based on the 5th edition in 2021, with reference to the latest research progress at home and abroad. The new edition focuses on updates to antiviral therapy, comprehensive management, opportunistic infections, human immunodeficiency virus (HIV) infection complicated with tumors, prevention and intervention of HIV infection, and newly introduces the section on "immunological non-responder (INR) in AIDS", which for the first time proposes the concept of "vulnerable populations with AIDS", and provides recommendations for diagnosis and treatment, as well as evidence and strength of the recommendations. The new edition covers epidemiology, etiological characteristics, laboratory testing, pathogenesis, clinical manifestations and staging, diagnostic criteria, common opportunistic infections, antiviral therapy, immune reconstitution inflammatory syndrome, INR, AIDS-related tumors, prevention of mother-to-child vertical transmission of HIV and fertility in single-positive families, pre- and post-exposure prophylaxis and interruption of HIV infection, comprehensive management of HIV infection, etc. It aims to assist clinicians in making rational decisions in the diagnosis, treatment, and management of AIDS. It will also be regularly revised and updated according to research progress at home and abroad.

Neck injection aesthetic, a commonly performed clinical procedure, is still lacking in comprehensive guidelines or consensus. This expert consensus is co-authored by experts from the Injection Aesthetics of the National Quality Control Center of Plastic and Aesthetic Surgery. It elaborates on formulation method of consensus, the relevant contents of neck aesthetics and anatomy, botulinum toxin injections, filler injections, collagen stimulator injections, autologous tissue components injections, and combined treatments of injections with electrophoto-therapy. The consensus incorporates relevant evidence-based medical references, as well as multiple discussions. Ultimately, a basic clinical operational expert consensus was formulated, with the aim of serving as a reference for clinical physicians in their practice.

In order to promote the development of hair transplantation, particularly the establishment of standards, the Hair Transplantation Expert Group of Plastic and Aesthetic National Medical Quality Control Center invited experts in the field of hair transplantation across China and formed a draft of the Expert Consensus on Standard Terminology for Hair Transplantation based on the collation of relevant literature and monographs. By combining Delphi methodology and consensus meetings, the expert group conducted several rounds of consultations on issues such as follicular unit anatomy, harvesting, dissection, and implantation, ultimately presenting 54 terminologies. This consensus considers the original Chinese and English meanings as well as the professional characteristics of terms used in hair transplantation, highlights the unique features and advantages of hair transplantation, and preserves its essence while promoting innovation, with the hope of providing valuable reference for clinical researchers engaged in hair transplantation both domestically and internationally, and better facilitating the standardization and advancement of the field.

Localized scleroderma (LoS) is a chronic autoimmune skin disorder characterized by fibrosis and hardening of the skin and subcutaneous tissues, potentially affecting deeper tissues and other organs. Currently, China lacks evidence-based guidelines for the diagnosis and management of LoS, which poses a challenge to disease recognition and leads to significant variation in treatment strategies across medical centers. To address this problem, we plan to establish a nationwide, multidisciplinary expert team through the Chinese Society of Plastic Surgery to initiate the development of the Chinese Guideline for the Diagnosis and Management of Localized Scleroderma. The guideline aims to standardize the diagnosis and treatment procedures for LoS, improve clinical diagnostic and therapeutic capabilities, and enhance patient outcomes through early identification and intervention. The guideline will adhere to international standards, with recommendations formed through evidence evaluation and multiple rounds of expert discussions. Although evidence-based data on LoS specific to the Chinese population is currently limited, and no unified gold standard for disease assessment exists, the clinical expertise of multidisciplinary specialists will play a pivotal role in the guideline's formulation. We anticipate that this guideline will provide LoS patients with higher-quality medical care and enhance patient awareness and engagement, which may ultimately help reduce social and healthcare burden. This proposal outlines the background, methodology, and anticipated value of the guideline, with the hope of providing guidance for its rigorous development and successful publication.